Development and Validation of a Highly Sensitive LC‐MS/MS Method for the Quantification of N ‐Nitroso‐Desmethyl‐Zolmitriptan: A Nitrosamine Impurity in Zolmitriptan

Documenti analoghi

• Development and Validation of a Highly Sensitive LC‐MS/MS Method for Quantification of Mutagenic N ‐Nitroso Desmethyl Citalopram in Drug Formulations
  di: Bhaskar Vallamkonda, et al.
  Pubblicazione: (2025)
• Development and Optimization of a Sensitive LC–MS/MS Method for the Quantification of N‐Nitroso Bisoprolol in Pharmaceutical Formulations
  di: Rajesh Damarapurapu, et al.
  Pubblicazione: (2026)
• Quantitative LC‐MS/MS Method for Simultaneous Quantification of N ‐Nitroso‐Berotralstat and N ‐Nitroso‐Boc‐Berotralstat in Berotralstat.HCl
  di: Nagaraju Rajana, et al.
  Pubblicazione: (2025)
• Valsartan—Mutagenic Nitroso Drug Substance Related Impurity, Structural Evaluation, Carcinogenic Potency Categorization Assessment; a Novel and Extremely Sensitive Quantification Method for Impurity in Drug Substances Using LC‐MS/MS
  di: Sudhakar Vakkala, et al.
  Pubblicazione: (2026)
• Ultra‐Sensitive and Green LC–MS/MS Method for Trace‐Level Determination of Nitrosamine Drug Substance‐Related Impurities in the Anti‐Diuretic Drug Furosemide
  di: Santhosh Kumar Ettaboina, et al.
  Pubblicazione: (2026)